# OCT-based DAPT Cessation in HBR Patients

> **NCT07238764** · NA · COMPLETED · sponsor: **Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health** · enrollment: 40 (actual)

## Conditions studied

- High Bleeding Risk Patients
- DAPT(Dual Antiplatelet Therapy)
- Coronary Artery Disease
- Diabetes Mellitus

## Interventions

- **PROCEDURE:** Optical Coherence Tomography-based early DAPT discontinuation

## Key facts

- **NCT ID:** NCT07238764
- **Lead sponsor:** Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-12
- **Primary completion:** 2025-05-09
- **Final completion:** 2025-05-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07238764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07238764, "OCT-based DAPT Cessation in HBR Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07238764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*